Find latest Myeloma videos · 600+ videos

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub
B

Talquetamab as a Bridging Therapy to BCMA CAR-T in RRMM

By 2024 ASH Annual Meeting Insights Hub FEATURING Binod Dhakal
By 2024 ASH Annual Meeting Insights Hub FEATURING Binod Dhakal
161 views
December 31, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

12:58
Incyte

Spleen Volume Reduction and Long-Term Survival in Myelofibrosis: Whe…

Feat. R. Mesa

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy

2024 ASH Annual Meeting Insights Hub: Myeloma Videos

09:20

ASH 2024 Insights: Upfront Use of Anti-CD38 Monoclonal Antibodies in…

2024 ASH Annual Meeting Insights Hub

A. Khan

73 views
04:04

ASH 2024 Insights: Association of Pre-Treatment Biomarkers With Toxi…

2024 ASH Annual Meeting Insights Hub

D. Hansen

42 views
09:18

ASH 2024 Insights: Belamaf Monotherapy in Pts With R/R Light Chain A…

2024 ASH Annual Meeting Insights Hub

E. Kastritis

40 views
View All

Related Videos

21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.5K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

515 views
19:28

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implicati…

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

497 views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

809 views
13:28

Debate: Using BCMA CAR-T in Early vs Late Line R/R MM Treatment

Louisville Hematology Highlights

K. Patel, S. Usmani

207 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

389 views
08:58

Transition of Care for Bispecific Antibodies in RRMM: Closing the Ga…

Cleveland Clinic Taussig Cancer Institute

S. Mazzoni

137 views
11:20

Real-World Characteristics and Outcomes in Patients With RRMM Receiv…

Adeel Khan

153 views
11:17

CAR-T Strategies and Clinical Considerations for R/R MM

Moffitt Cancer Center

K. Patel

172 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

530 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

604 views
29:37

Making Sense in R/R Myeloma: Guideline-Based Current Approaches

Saurabh Chhabra

199 views
06:06

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

102 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

733 views
16:55

Anti-BMCA Bispecific Antibodies - Independent Symposium at the 10th …

Springer Healthcare IME

S. Usmani

228 views
05:55

ASH 2024 Insights: Efficacy of Anti-BCMA CAR-T in Myeloma Patients P…

2024 ASH Annual Meeting Insights Hub

J. Waldschmidt

158 views
30:09

Expert Roundtable: Future Directions in Managing NDMM - MRD, CAR-T, …

MyCancerHaven

R. Vij, P. Kapoor, M. Alsina, S. Mailankody, A. Nooka, S. Tuchman

129 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

662 views
09:07

CARTITUDE-4 Update: OS With Cilta-Cel vs. SOC in Len-Refractory Mult…

Maria-Victoria Mateos

251 views
AUTOPLAY